4-(2-Amino-thiazol-4-yl)-1-oxa-spiro[4.5]decan-2-one
95%
- Product Code: 75549
CAS:
137180-65-5
| Molecular Weight: | 252 g./mol | Molecular Formula: | C₁₂H₁₆N₂O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00440457 | |
| Melting Point: | Boiling Point: | 504.4℃ at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C, sealed and dry |
Product Description:
This compound is primarily utilized in pharmaceutical research and development due to its unique spirocyclic structure, which is often associated with bioactive properties. It serves as a key intermediate in the synthesis of various heterocyclic compounds, which are explored for their potential therapeutic applications. Researchers focus on its role in creating molecules that may exhibit antimicrobial, anti-inflammatory, or anticancer activities. Its structural features make it a valuable scaffold in drug discovery, particularly in the design of novel small-molecule inhibitors targeting specific enzymes or receptors. Additionally, it is studied for its potential use in developing treatments for neurological disorders, as its core structure can interact with biological targets in the central nervous system.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 1.000 | 10-20 days | £1,023.06 |
+
-
|
4-(2-Amino-thiazol-4-yl)-1-oxa-spiro[4.5]decan-2-one
This compound is primarily utilized in pharmaceutical research and development due to its unique spirocyclic structure, which is often associated with bioactive properties. It serves as a key intermediate in the synthesis of various heterocyclic compounds, which are explored for their potential therapeutic applications. Researchers focus on its role in creating molecules that may exhibit antimicrobial, anti-inflammatory, or anticancer activities. Its structural features make it a valuable scaffold in drug discovery, particularly in the design of novel small-molecule inhibitors targeting specific enzymes or receptors. Additionally, it is studied for its potential use in developing treatments for neurological disorders, as its core structure can interact with biological targets in the central nervous system.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :